Table 2 HFE genotypes in patients and controls
wt/wt | C282Y/wt | C282Y/C282Y | C282Y/H63D | H63D/wt | H63D/H63D | |
|---|---|---|---|---|---|---|
Controls (n = 34) | 26 | 4 | – | – | 4 | – |
NAFLD with normal iron stores (n = 22)a | 13 | 1 | – | – | 6* | 1 |
NAFLD with DIOS (n = 16) | 12 | 2 | – | – | 2 | – |
CLD (n = 8)b | 4 | – | – | – | 2 | – |
CLD-IO (n = 21) | 14 | 4 | – | – | 1 | 2 |
Compound heterozygous HH (n = 5) | – | – | – | 5 | – | – |
Homozygous HH (n = 12) | – | – | 12 | – | – | – |